Current minimally invasive techniques for ablation in superficial venous reflux are limited to thermal based systems requiring tumescent anesthesia, non-thermal chemical sclerosants and permanent glue implantation. The aim of this feasibility study was to determine the safety and efficacy of a novel mechanical-only ablation (MOA) device called EnVena, in a recognised large animal model with chronic follow up.
Methods
Venous ablation of six lateral saphenous veins in three sheep was performed using the EnVena device. Luminal patency and vein wall fibrosis were evaluated by histologic analysis at 51 and 89 days.
Results
All treated veins demonstrated fibrotic occlusion in contiguous segments at 51 and 89 days on histological analysis. From 45 consecutive segments spanning the treatment length across the six treated veins, 26 (57%) were fully occluded, 7 (16%) were impinged or partially occluded and 12 (27%) were open. There were no device related complications during the follow up period.
Conclusions
A purely mechanical approach to superficial venous ablation demonstrated safety and efficacy in a recognized large animal model based on histological findings.
RassKFringsNGlowackiP, et al. Same site recurrence is more frequent after endovenous laser ablation compared with high ligation and stripping of the great saphenous vein: 5 year results of a randomized clinical trial (RELACS study). Eur J Vasc Endovasc Surg2015; 50: 648–656.
2.
WhiteleyMSShiangoliIDos SantosSJ, et al. Fifteen year results of radiofrequency ablation, using VNUS closure, for the abolition of truncal venous reflux in patients with varicose veins. Eur J Vasc Endovasc Surg2017; 54: 357–362.
3.
TeterKAKabnickLSSadekM.Endovenous laser ablation: a comprehensive review. Phlebology2020; 35: 656–662.
4.
WollmannJC.The history of sclerosing foams. Dermatol Surg2004; 30: 694–703; discussion 703.
5.
Surveillance report 2016 – varicose veins in the legs (2013) NICE guideline CG168, London, 2016.
6.
O’DonnellTFJrandPassmanMA.Clinical practice guidelines of the Society for Vascular Surgery (SVS) and the American Venous Forum (AVF) – management of venous leg ulcers. Introduction. J Vasc Surg2014; 60: 1S–2S.
7.
Kürşat BozkurtALawaetzMDanielssonG, et al. European college of phlebology guideline for truncal ablation. Phlebology2020; 35: 73–83.
8.
BrittendenJCooperDDimitrovaM, et al. Five-year outcomes of a randomized trial of treatments for varicose veins. N Engl J Med2019; 381: 912–922.
9.
JiaXMowattGBurrJM, et al. Systematic review of foam sclerotherapy for varicose veins. Br J Surg2007; 94: 925–936.
10.
SufianSArnezALabropoulosN, et al. Incidence, progression, and risk factors for endovenous heat-induced thrombosis after radiofrequency ablation. J Vasc Surg Venous Lymphat Disord2013; 1: 159–164.
11.
KabnickLSSadekMBjarnasonH, et al. Classification and treatment of endothermal heat-induced thrombosis: recommendations from the American Venous Forum and the Society for Vascular Surgery. Phlebology2020; 36: 8–25.
12.
KabnickLSSadekMBjarnasonH, et al. Classification and treatment of endothermal heat-induced thrombosis: Recommendations from the american venous forum and the society for vascular surgery. J Vasc Surg Venous Lymphat Disord 2021; 9: 6–22. doi: 10.1016/j.jvsv.2020.06.008.
13.
DexterDKabnickLBerlandT, et al. Complications of endovenous lasers. Phlebology2012; 27: 40–45.
14.
BoersmaDvan HaelstSTvan EekerenRR, et al. Macroscopic and histologic analysis of vessel wall reaction after mechanochemical endovenous ablation using the ClariVein OC device in an animal model. Eur J Vasc Endovasc Surg2017; 53: 290–298.
15.
TalMGDos SantosSJMaranoJP, et al. Histologic findings after mechanochemical ablation in a caprine model with use of ClariVein. J Vasc Surg Venous Lymphat Disord2015; 3: 81–85.
16.
MohamedAHLeungCWallaceT, et al. A randomized controlled trial of endovenous laser ablation versus mechanochemical ablation with ClariVein in the management of superficial venous incompetence (LAMA trial). Ann Surg2020.
17.
HolewijnSvan EekerenRVahlA, et al. Two-year results of a multicenter randomized controlled trial comparing mechanochemical endovenous ablation to RADiOfrequeNcy ablation in the treatment of primary great saphenous vein incompetence (MARADONA trial). J Vasc Surg Venous Lymphat Disord2019; 7: 364–374.
18.
LaneTRMooreHMFranklinIJ, et al. Retrograde inversion stripping as a complication of the ClariVein mechanochemical venous ablation procedure. Ann R Coll Surg Engl2015; 97: e18–e20.
19.
ParkIJeongMHParkCJ, et al. Clinical features and management of “phlebitis-like abnormal reaction” after cyanoacrylate closure for the treatment of incompetent saphenous veins. Ann Vasc Surg2019; 55: 239–245.
20.
ParsiKRobertsSKangM, et al. Cyanoacrylate closure for peripheral veins: consensus document of the Australasian college of phlebology. Phlebology2020; 35: 153–175.
21.
Siller-MatulaJMPlasenzottiRSpielA, et al. Interspecies differences in coagulation profile. Thromb Haemost2008; 100: 397–404.
22.
van den BosRRMilleretRNeumannM, et al. Proof-of-principle study of steam ablation as novel thermal therapy for saphenous varicose veins. J Vasc Surg2011; 53: 181–186.
23.
KendlerMAverbeckMSimonJC, et al. Histology of saphenous veins after treatment with the ClariVein(R) device – an ex-vivo experiment. J Dtsch Dermatol Ges2013; 11: 348–352.
24.
WhiteleyMSDos SantosSJFernandez-HartTJ, et al. Media damage following detergent sclerotherapy appears to be secondary to the induction of inflammation and apoptosis: an immunohistochemical study elucidating previous histological observations. Eur J Vasc Endovasc Surg2016; 51: 421–428.
25.
BushRGShammaHNHammondK.Histological changes occurring after endoluminal ablation with two diode lasers (940 and 1319 nm) from acute changes to 4 months. Lasers Surg Med2008; 40: 676–679.
26.
HegerMvan GolenRFBroekgaardenM, et al. Endovascular laser-tissue interactions and biological responses in relation to endovenous laser therapy. Lasers Med Sci2014; 29: 405–422.
27.
ParkI.Human saphenous vein histopathology 2 years after cyanoacrylate closure using the VenaSeal system. Ann Vasc Surg2020.
28.
TeleniEAnnisonEF.Development of a sheep hind-limb muscle preparation for metabolic studies. Aust J Biol Sci1986; 39: 271–281.
